Glyset and Wellbaby DHA
Determining the interaction of Glyset and Wellbaby DHA and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:Miglitol may reduce the bioavailability of ranitidine by 60%. The mechanism of the interaction and clinical significance are unknown. If both drugs must be given together, the patient should be monitored for altered clinical response when either drug is started, stopped or changed in dosage.
- "Product Information. Glyset (miglitol)." Bayer, West Haven, CT.
Generic Name: omega-3 polyunsaturated fatty acids
Brand name: Proferrin-ES
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glyset-Wellbutrin
- Glyset-Wellbutrin SR
- Glyset-Wellbutrin Tablets
- Glyset-Wellbutrin XL
- Glyset-Wellcovorin
- Glyset-Wera
- Wellbaby DHA-Glyxambi
- Wellbaby DHA-GNP Antibiotic Plus Pramoxine
- Wellbaby DHA-GNP Cold Relief Plus
- Wellbaby DHA-GNP Day Time D Cold/Flu
- Wellbaby DHA-GNP Mercuroclear
- Wellbaby DHA-GNP Pre-Menstrual Relief Max Strength